Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.042 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |